ACET · Adicet Bio, Inc. · Exempt Offerings
$2.93
-0.06 (-2.01%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our recurring losses from operations incurred since inception, the expectation of continuing operating losses for the foreseeable future, our outstanding and future payment obligations, and the potential need to raise additional capital to finance our future operations, we have concluded that substantial doubt exists about our ability to continue as a going concern for a period at least twelve months from the date of issuance of these unaudited consolidated financial statements.”View the 10-Q filed Nov 5, 2026
Market Cap
$27.43M
Shares
9.36M
Volume · Nov 12
371.41K
Avg daily vol (3M)
226.86K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1720580
CUSIP
007002207
13F (30d)
37 filings
25 filers
Visit website
Investor relations